Initiative for Global Access to Medicines
The Initiative for Global Access to Medicines (IGAM) is a McMaster University-based organization that actively works to improve access to medicine through mobilizing Canadian politicians and stakeholders. They are known for advocating in favor of low-cost legislative interventions which incentivize the research, development, and distribution of pharmaceutical products targeting rare and neglected diseases. They have also spoken in favor of reforming Canada's Access to Medicines Regime (CAMR) and have worked to promote the Health Impact Fund (HIF).
Previous and current work
As of November 2013, IGAM's main project involves advocating for a Priority Review Voucher (PRV) system in Canada.[1][2] The system has been previously implemented in the United States. In 2013, the organization had talks with members of Health Canada and the Canadian Organization for Rare Disorders to discuss inserting legislation into the upcoming Canada Orphan Drug Framework scheduled to be passed in early 2014. The organization has also spoken in favor of reforming the Canadian Access to Medicines Regime, which it argues is ineffective.[3]
References
- ↑ Rachel Faber. (2013). Health Science students take learning outside the classroom. The Silhouette. [1]
- ↑ Nicole Jedrzejko, Christina Park, Zain Rizvi. (2013). Stimulating Canadian research and development for lifesaving medicines; the Priority Review Voucher. [2]
- ↑ Steven Hoffman and Zain Rizvi. (2013). Ten years of failure to provide medicine. "Archived copy". Archived from the original on December 3, 2013. Retrieved November 22, 2013.CS1 maint: Archived copy as title (link)
External links
This article "Initiative for Global Access to Medicines" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
